FDA clears Cepheid's multiplex respiratory panel test

The US FDA has granted clearance to Cepheid for its Xpert Respiratory Panel, a multiplex polymerase chain reaction (PCR) diagnostic test. The panel is designed to identify 13 common bacterial and viral respiratory pathogens from one nasopharyngeal swab. Xpert Respiratory Panel addresses diagnostic challenges associated with acute respiratory conditions. Credit: sasirin pamai/Shutterstock.com. The US Food and Drug Administration (FDA) has granted clearance to Cepheid for its Xpert Respiratory Panel, a multiplex polymerase chain reaction (PCR) diagnostic test. The panel is designed to identify 13 common bacterial and viral respiratory pathogens from one nasopharyngeal swab.` Combine business intelligence and editorial excellence…

Source: Medical Device Network